Frankenreiter Lisa, Gahr Bernd M, Schmid Hannes, Zimmermann Mirjam, Deichsel Sebastian, Hoffmeister Philipp, Turkiewicz Aleksandra, Borggrefe Tilman, Oswald Franz, Nagel Anja C
Department of General Genetics (190g), Institute of Biology (190), University of Hohenheim, Stuttgart, Germany.
Department of Internal Medicine 1, Center for Internal Medicine, University Medical Center Ulm, Ulm, Germany.
Front Cell Dev Biol. 2021 Apr 14;9:658820. doi: 10.3389/fcell.2021.658820. eCollection 2021.
The highly conserved Notch signaling pathway controls a multitude of developmental processes including hematopoiesis. Here, we provide evidence for a novel mechanism of tissue-specific Notch regulation involving phosphorylation of CSL transcription factors within the DNA-binding domain. Earlier we found that a phospho-mimetic mutation of the CSL ortholog Suppressor of Hairless [Su(H)] at Ser impedes DNA-binding. By genome-engineering, we now introduced phospho-specific mutants at the endogenous locus, encoding either a phospho-deficient [ ] or a phospho-mimetic [ ] isoform. mutants were defective of Notch activity in all analyzed tissues, consistent with impaired DNA-binding. In contrast, the phospho-deficient mutant did not generally augment Notch activity, but rather specifically in several aspects of blood cell development. Unexpectedly, this process was independent of the corepressor acting otherwise as a general Notch antagonist in . This finding is in agreement with a novel mode of Notch regulation by posttranslational modification of Su(H) in the context of hematopoiesis. Importantly, our studies of the mammalian CSL ortholog (RBPJ/CBF1) emphasize a potential conservation of this regulatory mechanism: phospho-mimetic RBPJ was dysfunctional in both the fly as well as two human cell culture models, whereas phospho-deficient RBPJ rather gained activity during fly hematopoiesis. Thus, dynamic phosphorylation of CSL-proteins within the DNA-binding domain provides a novel means to fine-tune Notch signal transduction in a context-dependent manner.
高度保守的Notch信号通路控制着包括造血作用在内的众多发育过程。在此,我们提供了一种组织特异性Notch调节新机制的证据,该机制涉及DNA结合域内CSL转录因子的磷酸化。此前我们发现,CSL直向同源物无翅型抑制因子[Su(H)]在丝氨酸处的磷酸模拟突变会阻碍DNA结合。通过基因组工程,我们现在在内源基因座引入了磷酸特异性突变体,其编码磷酸缺陷型[ ]或磷酸模拟型[ ]异构体。突变体在所有分析的组织中Notch活性均有缺陷,这与DNA结合受损一致。相比之下,磷酸缺陷型突变体一般不会增强Notch活性,而是在血细胞发育的几个特定方面增强其活性。出乎意料的是,这一过程不依赖于共抑制因子,而该共抑制因子在其他情况下作为Notch的一般拮抗剂发挥作用。这一发现与造血过程中通过Su(H)的翻译后修饰进行Notch调节的新模式一致。重要的是,我们对哺乳动物CSL直向同源物(RBPJ/CBF1)的研究强调了这种调节机制的潜在保守性:磷酸模拟型RBPJ在果蝇以及两种人类细胞培养模型中均功能失调,而磷酸缺陷型RBPJ在果蝇造血过程中反而获得了活性。因此,DNA结合域内CSL蛋白的动态磷酸化提供了一种以依赖于上下文的方式微调Notch信号转导的新手段。